:::

詳目顯示

回上一頁
題名:探討精神分裂症病患出院後遵囑服藥與再住院關係之前瞻性研究
書刊名:護理雜誌
作者:邵文娟陳宏張雅芬林煒千林靜蘭
作者(外文):Shao, Wen-chuanChen, HungChang, Ya-fenLin, Wei-chenLin, Esther Ching-lan
出版日期:2013
卷期:60:5
頁次:頁31-40
主題關鍵詞:精神分裂症遵囑服藥表現前瞻性研究設計再住院SchizophreniaMedication adherenceProspective researchRehospitalization
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(5) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:5
  • 共同引用共同引用:3
  • 點閱點閱:36
背景:目前藥物治療為精神分裂症主要的治療方式,然而,其不遵囑治療的比例高達50-80%,實為不可忽視的照護挑戰,並且不遵囑治療與再發病之間具有顯著相關性。目的:探究精神分裂症病患出院後的遵囑服藥表現與再住院次數之間的相關性與預測性關係。方法:採前瞻性研究設計,以即將從精神科急性病房出院、且預計居住於社區之精神分裂症病患為研究對象,進行為期六個月的居家追蹤與評量,評量工具包括:遵囑服藥行為、遵囑服藥態度、服藥處方認知;並以病歷回顧同期間的再住院情形,進一步分析其間關係。結果:完成本研究病患共有77位,以男性、青壯年、未婚、整體功能偏中下、高中職畢業、出院後六個月內未再住院者居多。經迴歸模式分析發現:當出院後六個月內整體遵囑服藥表現、遵囑服藥態度以及服藥處方認知之分數提高時,會顯著降低再住院的相對風險(0.194-0.79倍)。結論/實務應用:精神分裂症病患出院後六個月期間遵囑服藥表現可預測其再住院之發生,未來宜針對此族群發展本土化出院規劃及社區追蹤處置。
Background: Antipsychotics have been regarded as the most effective therapy for schizophrenia; however, Taiwan's non-adherence rate for prescribed antipsychotics of 50-80% is an important issue that relates directly and significantly to schizophrenia patient relapse rates.Purposes: This study examines the correlational and predictive relationships between medication adherence and rehospitalization in schizophrenia patients discharged from an acute ward.Methods: This study used a prospective research design. Schizophrenia patients discharged from a psychiatric acute ward who stated their plan to live in the community were recruited as participants. Participant medication adherence was assessed via home visits during the 6-month follow-up period using scales including the Medication Adherence Questionnaire (MAQ), drug attitudes, and regimen knowledge. Rehospitalization data were retrieved from electronic medical records. Relationships between medication adherence and rehospitalization were analyzed using t-tests and regression analysis.Results: Seventy-seven patients with schizophrenia discharged from the acute ward were recruited in accordance with sampling criteria. The majority were male, young, unmarried, had poorer global function, had 12 years of education, and were not rehospitalized during the past 6-month period. Using binomial regression analysis, we found the relative risk for number of rehospitalizations during the 6-month period to be significantly less and the average scores for the total scale, attitude subscale, and knowledge subscale of medication adherence to have increased (0.194-0.79 times).Conclusions / Implications for Practice: Our findings support that better medication adherence in people with schizophrenia decreases rehospitalization risk. We urge clinicians to develop sensitive interventions to promote antipsychotics adherence in this population.
期刊論文
1.Hogan, T. P.,、Awad, A. G.,、Eastwood, R.(1983)。A self-report scale predictive of drug compliance in schizophrenics: Reliability and discriminative validity。Psychological Medicine,13,177-183。  new window
2.Boden, R.、Brant, L.、Kieler, H.、Andersen, M.、Reutfors, J.(2011)。Early non-adherence to medication and other risk factors for rehospitalization in schizophrenia and schizoaffective disorder。Schizophr Res,113,36-41。  new window
3.陳夏蓮、蔡仁貞(20120200)。症狀經驗、病因解釋與治療遵從行為--以高血壓病人為例。護理雜誌,59(1),5-10。new window  延伸查詢new window
4.Abdel-Baki, A、Ouellet-Plamondon, C.、Malla, A.(2012)。Pharmacotherapy challenges in patients with first-episode psychosis。Journal of Affective Disorders,138,3-14。  new window
5.Ascher-Svanum, H、Nyhuis, A. W、Stauffer, V.、Kinon, B. J.、Faries, D. E、Phillips, G. A.、Naber, D.(2010)。Reasons for discontinuation and continuation of antipsychotics in the treatment of schizophrenia from patient and clinician perspectives。Current Medical Research and Opinion,26(10),2403-2410。  new window
6.Beck, E. M.、Cavelti, M.、Wirtz, M、Kossowsky, J、Vauth, R.(2011)。How do socio-demographic and clinical factors interact with adherence attitude profiles in schizophrenia ? A cluster-analytical approach。Psychiatry Research,187(1-2),55-61。  new window
7.Bosworth, H. B.、Granger, B. B.、Mendys, P.、Brindis, R.、Burkholder,R.、Czajkowski, S. M、Granger, C. B(2011)。Medication adherence: A call for action。American Heart Journal,162(3),412-424。  new window
8.Bressington, D.、Mui, J.、Gray, R.(2013)。Factors associated with antipsychotic medication adherence in community-based patients with schizophrenia in Hong Kong: A cross sectional study。International Journal of Mental Health Nursing,22(1),35-46。  new window
9.Chang, C. M.、Wu, K. Y.、Liang, H. Y.、Wu, E. C. H.、Chen, C.Y.、Wu, C. S、Tsai, H. J.(2012)。Adherence patterns with first- versus second-generation antipsychotics for newly diagnosed schizophrenia in Taiwan。Psychiatric Services,63(5),504-507。  new window
10.Charrier, N.、Chevreul, K.、Durand-Zaleski, I.(2013)。The cost of schizophrenia: A literature review。L'Encéphale,39(1),S49-S56。  new window
11.DiMatteo, M. R.(2004)。Variations in patients’ adherence to medical recommendations: A quantitative review of 50 years of research。Medical Care,42(3),200-209。  new window
12.Dolder, C. R.、Lacro, J. P、Leckband, S.、Jeste, D. V.(2003)。Interventions to improve antipsychotic medication adherence:Review of recent literature。Journal of Clinical Psychopharmacology,23(4),389-399。  new window
13.Gaebel, W.、Riesbeck, M.、von Wilmsdorff, M.、Burns, T.、Derks, E. M.、Kahn, R. S、EUFEST Study Group(2010)。Drug attitude as predictor for effectiveness in firstepisode schizophrenia: Results of an open randomized trial(EUFEST)。European Neuropsychopharmacology,20(5),310-316。  new window
14.Gilmer, T. P.、Dolder, C. R.、Lacro, J. P.、Folsom, D. P.、Lindamer,L.、Garcia, P、Jeste, D. V.(2004)。Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia。American Journal of Psychiatry,161(4),692-699。  new window
15.Glick, I. D.、Stekoll, A.、H.Hays, S(2011)。The role of the family and improvement in treatment maintenance, adherence, and outcome for schizophrenia。Journal of Clinical Psychopharmacology,31(1),82-85。  new window
16.Hardeman, S. M.、Harding, R. K.(2010)。Simplifying adherence in schizophrenia。Psychiatric Services,61(4),405-408。  new window
17.Haynes, R. B.、Sackett, D. L.、Gibson, E. S.、Taylor, D. W.、Hackett, B. C.、Roberts, R. S、Johnson, A. L.(1976)。Improvement of medication compliance in uncontrolled hypertension。The Lancet,307(7972),1265-1268。  new window
18.Kao, Y. C、Liu, Y. P.(2010)。Compliance and schizophrenia:The predictive potential of insight into illness, symptoms, and side effects。Comprehensive Psychiatry,51(6),557-565。  new window
19.Kikkert, M. J、Barbui, C.、Koeter, M. W、David, A. S.、Leese,M、Tansella, M.、Schene, A. H.(2008)。Assessment of medication adherence in patients with schizophrenia: The Achilles heel of adherence research。The Jounal Nervous and Mental Disease,196(4),274-281。  new window
20.Kopelowicz, A.、Zarate, R.、Wallace, C. J.、Liberman, R. P.、Lopez,S. R、Mintz, J.(2012)。The ability of multifamily groups to improve treatment adherence in Mexican Americans with schizophrenia。Archives of General Psychiatry,69(3),265(273)。  new window
21.Lan, C. M.、Shiau, S. J、Lin, L. C.(2003)。Knowledge, Knowledge beliefs,attitudes, and drug compliance in schizophrenic patients。Tzu Chi Medical Journal,15(6),369-375。  new window
22.Leucht, S.、Tardy, M.、Komossa, K.、Heres, S.、Kissling, W.、Salanti, G.、Davis, J. M.(2012)。Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: A systematic review and meta-analysis。The Lancet,379(9831),2063-2071。  new window
23.Masand, P. S.、Roca, M.、Turner, M. S、Kane, J. M.(2009)。Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: A review。The Primary Care Companion to the Journal of Clinical Psychiatry,11(4),147-154。  new window
24.Misdrahi, D.、Petit, M、Blanc, O.、Bayle, F.、Llorca, P. M(2012)。The influence of therapeutic alliance and insight on medication adherence in schizophrenia。Nordic Journal of Psychiatry,66(1),49-54。  new window
25.Montes, J. M、Medina, E.、Gomez-Beneyto, M、Maurino, J(2012)。A short message service (SMS)-based strategy for enhancing adherence to antipsychotic medication in schizophrenia。Psychiatry Research,200(2-3),89-95。  new window
26.Mutschler, J.、von Zitzewitz, F、Rössler, W.、Grosshans, M.(2012)。Application of electronic diaries in patients with schizophrenia and bipolar disorders。Psychiatria Danubina,24(2),206-210。  new window
27.Quirk, A.、Chaplin, R.、Hamilton, S.、Lelliott, P.、Seale, C.(2013)。Communication about adherence to long-term antipsychotic prescribing: An observational study of psychiatric practice。Social Psychiatry and Psychiatric Epidemiology,,48(4),639-647。  new window
28.Remington, G.、Kwon, J.、Collins, A、Laporte, D.、Mann, S、Christensen, B.(2007)。The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia。Schizophrenia Research,90(1-3),229-237。  new window
29.Shelton, P. S、Mozingo, D. B.、Avissar, P. S.、Karg, M.、Charboneau,A. L、Rich, W(2012)。Measuring adherence in a community-based elderly population。The Consultant Pharmacist,27(11),771-781。  new window
30.Tiihonen, J.、Haukka, J、Taylor, M.、Haddad, P. M、Patel, M.X、Korhonen, P.(2011)。A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia。American Journal of Psychiatry,168(6),603-609。  new window
31.Tsai, J. K.、Lin, W. K、Lung, F. W.(2011)。Social interaction and drug attitude effectiveness in patients with schizophrenia。Psychiatric Quarterly,82(4),343-351。  new window
32.Tzeng, J. I.、Chang, C. C.、Chang, H. J、Lin, C. C(2008)。Assessing analgesic regimen adherence with the morisky medication adherence measure for Taiwanese patients with cancer pain。Journal of Pain and Symptom Management,36(2),157-166。  new window
33.Velligan, D. I.、Weiden, P. J.、Sajatovic, M.、Scott, J.、Carpenter, D.、Ross, R.、Docherty, J. P.(2010)。Assessment of adherence problems in patients with serious and persistent mental illness: Recommendations from the expert consensus guidelines。Journal of Psychiatric Practice,16(1),34-45。  new window
34.Yang, J.、Ko, Y. H.、Paik, J. W、Lee, M. S.、Han, C.、Joe, S. H.、Kim, S. H.(2012)。Symptom severity and attitudes toward medication: Impacts on adherence in outpatients with schizophrenia。Schizophrenia Research,134(2/3),226-231。  new window
35.Mueser, K. T.、McGurk, S. R.(2004)。Schizophrenia。The Lancet,363(9426),2063-2072。  new window
36.Morisky, D. E.、Green, L. W.、Levine, D. M.(1986)。Concurrent and predictive validity of a self-reported measure of medication adherence。Medical Care,24(1),67-74。  new window
37.Thompson, K.、Kulkarni, J.、Sergejew, A. A.(2000)。Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses。Schizophrenia Research,42(3),241-247。  new window
學位論文
1.林美吟(2008)。預測精神分裂症病患藥物遵從性的影響因素分析(碩士論文)。高雄醫學大學。  延伸查詢new window
2.陳美蘭(2010)。社區精神分裂病人病識感、服藥遵從行為及其影響因素之探討(碩士論文)。美和技術學院。  延伸查詢new window
其他
1.World Health Organization.(2013)。Adherence to longterm therapies: Evidence for action,http://www.who.int/hiv/pub/prev_care/lttherapies/en/index.html。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
:::
無相關博士論文
 
無相關書籍
 
無相關著作
 
QR Code
QRCODE